Renovaro BiosciencesRENB 
$0.53-2.96%24h
-2.96%24h
Global rank27151
Market cap$29.54M
Change 7d-16.67%
YTD Performance-83.33%
SP500 benchmarkUnderperform
P/E-0.74
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
EPS for Renovaro Biosciences (RENB)
Renovaro Biosciences has an EPS of $-0.71. In 2022, the company made an earnings per share (EPS) of $-2.16. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for RENB
-
Value:-
EPS history for Renovaro Biosciences from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.71 | -67.13% |
| 2022 | -$2.16 | 278.95% |
| 2021 | -$0.57 | 128.00% |
| 2020 | -$0.25 | - |
View the highest EPS stocks
